Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000673908 | SCV000799163 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2018-04-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000673908 | SCV000957532 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2023-11-08 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val433Glufs*37) in the CAPN3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CAPN3 are known to be pathogenic (PMID: 10330340, 15689361). This variant is present in population databases (no rsID available, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with limb-girdle muscular dystrophy (PMID: 15733273). ClinVar contains an entry for this variant (Variation ID: 557732). For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV001784288 | SCV002018078 | pathogenic | not provided | 2023-06-21 | criteria provided, single submitter | clinical testing | |
Neuberg Centre For Genomic Medicine, |
RCV000673908 | SCV004100577 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | criteria provided, single submitter | clinical testing | ||
Baylor Genetics | RCV003472162 | SCV004211565 | pathogenic | Muscular dystrophy, limb-girdle, autosomal dominant 4 | 2023-11-13 | criteria provided, single submitter | clinical testing |